Step Into the Future of Precision Health Screening and join us at ECR 2024Book a meeting
Retrospective analysis of radiotherapy plans for prostate cancer after revision of MRI targeted lesions detected by Quantib
ANNUAL MEETING OF THE ITALIAN SOCIETY OF URO-ONCOLOGY (SIURO), 2023
Petrucci et al,
October 3, 2023
Retrospective evaluation coverage of therapy plans in 5 subjects with prostate cancer who underwent hypofractionated radiotherapy.
These preliminary results showed that Quantib can assist the identification of target lesions, and confirmed optimal radiotherapy coverage of the target volume and a subsequent biochemical response at minimal follow-up.
This collected information is necessary to provide you with the critical features available on our Website. Because this information is essential to your experience, you are unable to alter these settings and still use the Website.
This information is used to enhance your experience on our Website. If we are unable to collect this important yet non-essential information, certain functions and items will not be available or work as intended.